It has been reported that some risk pathways such as TGF-β signaling pathway and inflammatory bowel disease and risk biological processes such as chondrocyte differentiation and regulation of cartilage development are involved in the OA pathology [56]. The gene discussed is TGFB1; the disease is inflammatory bowel disease.